The use of AChE inhibitors in the therapy of Alzheimer’s disease (AD) has since then ensured a continuous interest in the search for new molecules acting as AChE/BChE inhibitors. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.